Icon Advisers Inc Ligand Pharmaceuticals Inc Transaction History

Icon Advisers Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 01, 2019	SELL	$105.93 - $142.47 $3.31 Million - $4.45 Million	-31,229 Closed	0 $0
Q4 2018 Feb 04, 2019	SELL	$128.36 - $272.13 $96,398 - $204,369	-751 Reduced 2.35%	31,229 $4.24 Million
Q3 2018 Nov 05, 2018	SELL	$211.18 - $274.49 $1.81 Million - $2.35 Million	-8,579 Reduced 21.15%	31,980 $8.78 Million
Q1 2018 Apr 30, 2018	BUY	$138.63 - $182.62 $2.98 Million - $3.92 Million	21,484 Added 112.63%	40,559 $6.7 Million
Q3 2017 Nov 08, 2017	BUY	$120.91 - $137.94 $2.31 Million - $2.63 Million	19,075	19,075 $2.6 Million

348

20.2M

19K

11.5K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $3.39B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Icon Advisers Inc with notifications on news.